Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Enveric Biosciences, Inc. (AMRH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/03/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Announces its Psybrary™ Portfolio Now Totals Over 1000 Psychedelic-Inspired Therapeutic Candidates"
09/27/2023 8-K Quarterly results
08/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Completes Manufacturing of EB-373 to Supply Drug Material for Completion of Preclinical Program"
08/14/2023 8-K Quarterly results
Docs: "Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results"
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/24/2023 8-K Quarterly results
07/17/2023 8-K Quarterly results
06/08/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
06/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition"
06/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
05/24/2023 8-K Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen...
05/24/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Receives Notice of Allowance from USPTO for C4-Carboxylic Acid-substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug"
05/19/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences to Participate in 2023 BIO International Convention in Boston"
05/18/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/19/2023 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
04/03/2023 8-K Quarterly results
Docs: "Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results Key Highlights"
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1study of EB-373"
03/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications"
03/14/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery"
02/28/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Services to be Provided by Executive",
"Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635"
02/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635"
02/14/2023 SC 13G AdvisorShares Trust reports a 5.6% stake in Enveric Biosciences, Inc.
02/08/2023 SC 13G/A INTRACOASTAL CAPITAL, LLC reports a 9.4% stake in Enveric Biosciences, Inc.
02/07/2023 SC 13G Hudson Bay Capital Management LP reports a 5% stake in Enveric Biosciences, Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/20/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/28/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
10/06/2022 8-K/A Quarterly results
09/23/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy